The Priority Review

Tag

Novartis Pharmaceuticals

1 story

  1. Clinical trials

    Novartis registers Phase IIIb trial of zigakibart + atrasentan in primary IgA nephropathy

    This study was first posted on ClinicalTrials.gov on September 30, 2026. The trial plans to enroll 340 participants and plans to start December 1, 2026.